Pay in 4 interest-free payments of $7.44 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
LY3437943 is a new triple agonist peptide that affects the glucagon receptor (GCGR), the glucose-dependent insulinotropic polypeptide receptor (GIPR), and the glucagon-like peptide-1 receptor (GLP-1R)
Peripheral neuropathy evaluations of patients with prolonged long COVID
Prime Health acts primarily as a technology platform to connect you with professional clinicians who may be available to provide you with non-emergency care
Taking L-arginine along with medications for high blood pressure might cause your blood pressure to go too low
Eli Lilly's TRIUMPH program includes trials covering obesity, cardiovascular disease, knee osteoarthritis, and long-term cardiovascular outcomes
US$ 23.22
US$ 21.26
US$ 21.01
